Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF.
暂无分享,去创建一个
Robert J Fisher | Glenn D Prestwich | Robert A Peattie | G. Prestwich | R. Fisher | X. Shu | Shenshen Cai | Kyle R. Pomraning | R. Peattie | M. Firpo | Xiao Zheng Shu | Shenshen Cai | Daniel B. Pike | Matthew A Firpo | Daniel B Pike | Kyle R Pomraning
[1] B. Matthews,et al. Three-dimensional structure of human basic fibroblast growth factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[2] G. Prestwich,et al. Functionalized derivatives of hyaluronic acid oligosaccharides: drug carriers and novel biomaterials. , 1994, Bioconjugate chemistry.
[3] R. Maier,et al. Anti-inflammatory drug delivery from hyaluronic acid hydrogels , 2004, Journal of biomaterials science. Polymer edition.
[4] Robert J Fisher,et al. Dual growth factor-induced angiogenesis in vivo using hyaluronan hydrogel implants. , 2006, Biomaterials.
[5] S. Sprang,et al. Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1 beta. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[6] Y. M. Elçin,et al. Extensive in vivo angiogenesis following controlled release of human vascular endothelial cell growth factor: implications for tissue engineering and wound healing. , 2001, Artificial organs.
[7] R. Jain. Tumor angiogenesis and accessibility: role of vascular endothelial growth factor. , 2002, Seminars in oncology.
[8] S. Soker,et al. Vascular endothelial growth factor is inactivated by binding to alpha 2-macroglobulin and the binding is inhibited by heparin. , 1993, The Journal of biological chemistry.
[9] R. Johnson,et al. Isoforms of Vascular Endothelial Growth Factor Act in a Coordinate Fashion To Recruit and Expand Tumor Vasculature , 2000, Molecular and Cellular Biology.
[10] G. Prestwich,et al. Synthesis and in vitro degradation of new polyvalent hydrazide cross-linked hydrogels of hyaluronic acid. , 1997, Bioconjugate chemistry.
[11] G. Prestwich,et al. Profiles Therapeutic applications of hyaluronic acid and hyaluronan derivatives , 1998 .
[12] P. Carmeliet. Angiogenesis in health and disease , 2003, Nature Medicine.
[13] P. Yurchenco,et al. Modulation of angiogenesis in vitro by laminin-entactin complex. , 1994, Developmental biology.
[14] Joseph S. Wall,et al. Relative Nucleophilic Reactivities of Amino Groups and Mercaptide Ions in Addition Reactions with α,β-Unsaturated Compounds1,2 , 1965 .
[15] J. Forrester,et al. Inhibition of phagocytosis by high molecular weight hyaluronate. , 1980, Immunology.
[16] J. Hubbell,et al. Systematic modulation of Michael-type reactivity of thiols through the use of charged amino acids. , 2001, Bioconjugate chemistry.
[17] G. Nagy,et al. Physiological and pathological angiogenesis in the endocrine system , 2003, Microscopy research and technique.
[18] Christopher J. Robinson,et al. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. , 2001, Journal of cell science.
[19] G. Prestwich,et al. Biocompatibility and stability of disulfide-crosslinked hyaluronan films. , 2005, Biomaterials.
[20] Haruchika Masuda,et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization , 1999, Nature Medicine.
[21] S. Kumar,et al. Application of angiogenic oligosaccharides of hyaluronan increases blood vessel numbers in rat skin. , 1994, The Journal of investigative dermatology.
[22] D. Gospodarowicz,et al. Heparin protects basic and acidic FGF from inactivation , 1986, Journal of cellular physiology.
[23] M. Morley,et al. Making and reading microarrays , 1999, Nature Genetics.
[24] Glenn D Prestwich,et al. In situ crosslinkable hyaluronan hydrogels for tissue engineering. , 2004, Biomaterials.
[25] Glenn D Prestwich,et al. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. , 2005, Biomaterials.
[26] Till Acker,et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions , 2001, Nature Medicine.
[27] J. Hubbell,et al. Conjugate addition reactions combined with free-radical cross-linking for the design of materials for tissue engineering. , 2001, Biomacromolecules.
[28] T. Fan,et al. Angiogenesis in a delayed revascularization model is accelerated by angiogenic oligosaccharides of hyaluronan. , 1995, Laboratory investigation; a journal of technical methods and pathology.
[29] J. Porter,et al. A modification of the Ellman procedure for the estimation of protein sulfhydryl groups. , 1967, Archives of biochemistry and biophysics.
[30] R Langer,et al. Controlled and modulated release of basic fibroblast growth factor. , 1991, Biomaterials.
[31] A A Poot,et al. Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[32] Jeffrey D. Esko,et al. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor , 1991, Cell.
[33] D. Ribatti,et al. The role of fibroblast growth factor‐2 in the vascularization of the chick embryo chorioallantoic membrane , 2002, Journal of cellular and molecular medicine.
[34] G. Prestwich,et al. Novel Hydrogels of Hyaluronic Acid: Synthesis, Surface Morphology, and Solid-State NMR , 1994 .
[35] J. Folkman,et al. Control of angiogenesis by heparin and other sulfated polysaccharides. , 1992, Advances in experimental medicine and biology.
[36] D. Rees,et al. Three-dimensional structures of acidic and basic fibroblast growth factors. , 1993, Science.
[37] A. Luttun,et al. Vascular progenitors: from biology to treatment. , 2002, Trends in cardiovascular medicine.
[38] Fabio Palumbo,et al. Disulfide-crosslinked hyaluronan-gelatin hydrogel films: a covalent mimic of the extracellular matrix for in vitro cell growth. , 2003, Biomaterials.
[39] S. Paku,et al. First steps of tumor-related angiogenesis. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[40] R. Bednar,et al. Reactivity and pH dependence of thiol conjugation to N-ethylmaleimide: detection of a conformational change in chalcone isomerase. , 1990, Biochemistry.
[41] Glenn D Prestwich,et al. Injectable synthetic extracellular matrices for tissue engineering and repair. , 2006, Advances in experimental medicine and biology.
[42] N. Ferrara,et al. The biology of VEGF and its receptors , 2003, Nature Medicine.
[43] B. Toole,et al. Hyaluronate inhibition of cell proliferation. , 1987, Arthritis and rheumatism.
[44] S. Kumar,et al. Does hyaluronan have a role in endothelial cell proliferation of the synovium? , 1992, Seminars in arthritis and rheumatism.
[45] Y. Ikada,et al. Controlled release of growth factors based on biodegradation of gelatin hydrogel , 2001, Journal of biomaterials science. Polymer edition.
[46] I. Hampson,et al. Angiogenesis induced by degradation products of hyaluronic acid. , 1985, Science.
[47] A. Caplan,et al. Substrate-bonded hyaluronic acid exhibits a size-dependent stimulation of chondrogenic differentiation of stage 24 limb mesenchymal cells in culture. , 1986, Developmental biology.
[48] Glenn D Prestwich,et al. Disulfide cross-linked hyaluronan hydrogels. , 2002, Biomacromolecules.
[49] S. Schwendeman,et al. Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide) , 2000, Nature Biotechnology.
[50] Napoleone Ferrara,et al. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications. , 2002, Seminars in oncology.
[51] I. Walter‐Sack,et al. Heparin-mediated selective release of hepatocyte growth factor in humans. , 2000, British journal of clinical pharmacology.
[52] J. Isner,et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cells , 1999, The EMBO journal.
[53] D E Ingber,et al. Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix , 1989, The Journal of cell biology.
[54] G. Prestwich,et al. Stimulation of in vivo angiogenesis by cytokine-loaded hyaluronic acid hydrogel implants , 2004 .
[55] G. Neufeld,et al. Platelet Factor-4 Inhibits the Mitogenic Activity of VEGF121 and VEGF165 Using Several Concurrent Mechanisms (*) , 1995, The Journal of Biological Chemistry.
[56] S. Kumar,et al. The role of hyaluronan in tumour neovascularization (review) , 1995, International journal of cancer.
[57] A. Suhardja,et al. Role of growth factors and their receptors in proliferation of microvascular endothelial cells , 2003, Microscopy research and technique.
[58] Glenn D Prestwich,et al. Attachment and spreading of fibroblasts on an RGD peptide-modified injectable hyaluronan hydrogel. , 2004, Journal of biomedical materials research. Part A.
[59] G. Prestwich,et al. Novel biomaterials for drug delivery , 2001 .
[60] Glenn D Prestwich,et al. Accelerated repair of cortical bone defects using a synthetic extracellular matrix to deliver human demineralized bone matrix , 2006, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[61] S. Kumar,et al. The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. , 1989, Experimental cell research.